We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+6.66%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$15.1B
AUM Growth
+$742M
Cap. Flow
-$196M
Cap. Flow %
-1.3%
Top 10 Hldgs %
36.33%
Holding
1,380
New
61
Increased
578
Reduced
366
Closed
37

Sector Composition

Rank Sector Weight
1 Real Estate 54.29%
2 Technology 12.23%
3 Consumer Discretionary 4.83%
4 Communication Services 4.52%
5 Healthcare 4.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QURE icon
1226
uniQure
QURE
$2.47B
$2K ﹤0.01%
158
QYLD icon
1227
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.01B
0
RAPT
1228
DELISTED
RAPT Therapeutics
RAPT
$2K ﹤0.01%
13
SPRY icon
1229
ARS Pharmaceuticals
SPRY
$572M
$2K ﹤0.01%
367
SRRK icon
1230
Scholar Rock
SRRK
$5.82B
$2K ﹤0.01%
208
TARS icon
1231
Tarsus Pharmaceuticals
TARS
$2.63B
$2K ﹤0.01%
107
TBPH icon
1232
Theravance Biopharma
TBPH
$875M
$2K ﹤0.01%
215
TSVT
1233
DELISTED
2seventy bio
TSVT
$2K ﹤0.01%
152
VOO icon
1234
Vanguard S&P 500 ETF
VOO
$972B
0
VT icon
1235
Vanguard Total World Stock ETF
VT
$76.5B
0
VTI icon
1236
Vanguard Total Stock Market ETF
VTI
$657B
0
PETQ
1237
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$2K ﹤0.01%
99
ICPT
1238
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$2K ﹤0.01%
167
ABOS icon
1239
Acumen Pharmaceuticals
ABOS
$170M
$1K ﹤0.01%
165
ABUS icon
1240
Arbutus Biopharma
ABUS
$867M
$1K ﹤0.01%
395
ALLK
1241
DELISTED
Allakos
ALLK
$1K ﹤0.01%
343
ALXO icon
1242
ALX Oncology
ALXO
$266M
$1K ﹤0.01%
138
AVIR icon
1243
Atea Pharmaceuticals
AVIR
$311M
$1K ﹤0.01%
242
BCAB icon
1244
BioAtla
BCAB
$5.43M
$1K ﹤0.01%
4
CDXS icon
1245
Codexis
CDXS
$136M
$1K ﹤0.01%
189
CGEM icon
1246
Cullinan Oncology
CGEM
$1.04B
$1K ﹤0.01%
127
CHRS icon
1247
Coherus Oncology
CHRS
$221M
$1K ﹤0.01%
262
CMPS
1248
Compass Pathways
CMPS
$1.46B
$1K ﹤0.01%
64
CNTA
1249
DELISTED
Centessa Pharmaceuticals
CNTA
$1K ﹤0.01%
211
CRBU icon
1250
Caribou Biosciences
CRBU
$149M
$1K ﹤0.01%
176

Similar funds

Daiwa Securities Group's Q2 2023 Portfolio in Review

As of Q2 2023, Daiwa Securities Group held 1,380 positions worth $15.1B, up 5.2% from $14.4B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Daiwa Securities Group's Q2 2023 filing shows 61 new, 578 increased, 366 reduced and 37 closed positions. Its largest new stake was Applovin: 95,413 shares worth $2.46M. The largest sale was Public Storage, an estimated $213M.

By sector, the portfolio is most concentrated in Real Estate at 54% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Daiwa Securities Group's largest Q2 2023 buy was Applovin: 95,413 shares worth $2.46M.
  • Daiwa Securities Group added most to Simon Property Group in Q2 2023, an estimated $105M increase.
  • Daiwa Securities Group's biggest Q2 2023 reduction was Public Storage, cutting an estimated $213M.
  • Daiwa Securities Group fully exited BWX Technologies in Q2 2023, selling an estimated $6.7M.
  • Daiwa Securities Group's ten largest holdings make up 36% of its $15.1B portfolio in Q2 2023.
  • Daiwa Securities Group opened 61 new positions and closed 37 in Q2 2023.
  • Daiwa Securities Group's portfolio value rose 5.2% quarter-over-quarter to $15.1B.

Based on Daiwa Securities Group's 13F filing for Q2 2023, filed 31 Jul 2023.